Posts Tagged ‘Lymphatic Filariasis’

Reading List 8/31/2010

August 31st, 2010

A new list of reads for your reading pleasure! Today we’re reading about a successful experimental treatment for victims of trachoma, the current state of global immunization, the spread of trachoma within the Northern Bahr el Ghazal region of Sudan, and Lymphatic filariasis in India.

Experimental vision cure proves successful, Thomas H. Maugh, Los Angeles Times
Global immunizations hit record but miss millions, David Morgan, Reuters
Mystery eye disease spreads across Northern Bahr el Ghazal, Ngor Arol Garang, Sudan Tribune
Lymphatic filariasis in India: Epidemiology and control measures, S Sabesan, P Vanamail, KHK Raju, P Jambulingam, Journal of Postgraduate Medicine

Reading List 8/25/2010

August 25th, 2010

A great new list of reads to get you through the week! Today we’re reading about a Lancet seminar on lymphatic filariasis and onchocerciasis, a great overview of drugs available to treat NTDs, Merck’s provision of funds to fight against HIV/AIDS in Botswana, and the use of roundworm in a new groundbreaking study. Enjoy!

Lancet seminar: lymphatic filariasis and onchocerciasis, NeLM news service
Medications to Treat Human Worms, Amy O’Connell, Live Strong
Merck Provides New Funding to Fight HIV/AIDS in Botswana, PharmaLive
Study of cell division sheds light on special mechanism in egg cells, Lab Spaces

Worm of the Week – Lymphatic Filariasis

August 24th, 2010

Another installment from our Worm of the Week series, courtesy of student campaigners from Boston University! Today we feature:

Lymphatic Filariasis


Wuchereria bancrofti AND Brugia malayi AND Brugia timori

Lymphatic Filariasis

A physically and socially debilitating disease, lymphatic filariasis affects over 120 million people in 80 different countries. The thread-like parasitic filarial worms, Wuchereria bancrofti (causing most infections worldwide), and Brugia malayi and Brugia timori (primarily in Asia) lodge in the human lymphatic system. There, adult worms mate and produce millions of microscopic microfilariae that circulate in the person’s blood. Infection spreads by mosquito bites containing larval worms that travel to lymph and grow into adults which takes about six months. Adult worms can live 5 to 7 years.

Symptoms

Sometimes called elephantiasis due to the engorgement and thickening of skin, lymphatic filariasis is characterized by lymphedema, or fluid collection due to improper functioning of the lymph system resulting in swelling. Most infected individuals are asymptomatic and will never develop symptoms. In the severest cases, fluid accumulates in the legs, arms, breasts, and genitalia. Infected persons are at increased risk for bacterial infections in the skin and lymph system.

Diagnosis

Microscopic identification of microfilariae in blood smear. Blood collection should be done at night.

Treatment

Diethylcarbamazine (DEC) kills microfilaria and some of the adult worms; Ivermectin kills microfilaria.

Prevention and Control

The best way to avoid lymphatic filariasis is to avoid mosquito bites (sleep under mosquito net, use repellent, wear long sleeves and trousers). In 1997, the World Health Assembly called for the global elimination of lymphatic filariasis as a public health problem. The strategy for elimination is based on treating everyone eligible to take the medicine living in an affected community with a dose of two drugs: albendazole is used in conjunction with ivermectin (sub-Saharan Africa) and with DEC (elsewhere in world).

Sources: http://www.cdc.gov/ncidod/dpd/parasites/lymphaticfilariasis/index.htm

http://www.cartercenter.org/health/lf/index.html

Just 50 cents campaign: http://www.globalnetwork.org/just50cents

World Mosquito Day

August 20th, 2010

By: Nathaniel Wolf, Sabin Vaccine Institute

August 20th is World Mosquito Day.  In 1897, Sir Ronald Ross looked at a mosquito under a microscope and saw that it looked really cool up close.  He declared August 20th World Mosquito Day and said we should be nice to mosquitoes, if only one day a year. 

Not really.  What Dr. Ross discovered was the link between mosquitoes and transmission of malaria.  He declared World Mosquito Day so that people would become educated about the life cycle of malaria, and in 1902 he won the Nobel Prize in Medicine for it.   In spite of this discovery, today the disease continues to be a threat to approximately 2.85 billion people, afflicting 250 million people around the world and causing an estimated 1 million deaths annually.   

» Read more: World Mosquito Day

Are Certain Global Health Initiatives Disrupting Basic Medical Care In Poor Countries?

August 19th, 2010

Women outside clinic in Gashora, Rwanda. Photo: Lindsay Wheeler

It’s hard to argue against the fact that there are many global health interventions that can go a long way toward the control and elimination of  many neglected tropical diseases (NTDs). Global health initiatives have become an intrinsic part of international aid policy.

At a low financial cost, single disease campaigns  in various countries like Rwanda, Burundi, Mali and Sierra Leone for instance, have seen success in deworming children and treating patients for schistosomiasis, onchocerciasis, and trachoma.

» Read more: Are Certain Global Health Initiatives Disrupting Basic Medical Care In Poor Countries?

End the Neglect Blog Round Up 8/13/2010

August 13th, 2010

Happy Friday readers!

Here’s our weekly roundup:

  1.  On Monday we highlighted a story about an NTD program that provides meals to school children before giving them treatment for schistosomiasis.
  2. On Tuesday, a great organization LEPRA Health In Action guest blogged about integrated programs between Leprosy and Lymphatic Filariasis
  3. On Wednesday, our frequently contributing writer and global health guru Alanna Shaikh gave us some good news about Buruli Ulcer
  4. On Thursday we told you about a new feature on the Council on Foreign Relations website called The Global Governance Monitor
  5. And Today, Friday we had two great items for you: 1) A New Global Helminth Atlas that will be a great NTD advocacy tool 2) The latest edition of The Lancet included an article about Africa’s need for improved access to treatment for schistosomiasis.

Integrated Programs for Disability Prevention

August 10th, 2010

By: LEPRA Health In Action

Washing is an important self care technique to prevent and treat LF and Leprosy patients. Photo Credit: LEPRA Health in Action

According to The World Health Organization a ‘fundamental prerequisite for accelerating the elimination of lymphatic filariasis, is the integration of the programme with other disease control/eradication programmes’. Disability prevention is however an essential part of LF elimination.  

Where people are already affected by the mosquito borne disease LEPRA Health in Action has found that an integrated approach using self-care techniques to treat patients with LF along with leprosy and other lower limb disabilities is reaping rewards.

In places like Bangladesh and northern India there are few specialist services to help disabled people and government health centres are often only able to offer primary health care. The result is that preventable disability can occur. In addition to the physical effects of these diseases patients’ self-esteem and economic well-being can also be affected. » Read more: Integrated Programs for Disability Prevention

Millions and Billions

July 26th, 2010

Photo Credit: Lindsay Wheeler

By: Tara Hayward, Resource Development Officer, Sabin Vaccine Institute

The economy has started to thaw and donors of the world are beginning to relax. Bill and Melinda Gates, along with Warren Buffett, have a launched an epic challenge for the world’s billionaires – Give away half of what you have.  While The Giving Pledge is specifically focused on billionaires, it feeds on inspiration from philanthropic efforts that encourage everyone – of all financial means and backgrounds. We all can help make the world a better place, right?

In the context of all the millions and billions of dollars floating around, as donors, we naturally start to wonder if we can do anything, if we can make any impact with a $20 donation to our favorite cause. The answer? Yes!

» Read more: Millions and Billions

Reading List 7/20/2010

July 20th, 2010

As the 8th Annual International AIDS Conference takes place in Vienna, Austria this week, we would like to highlight some articles with news on HIV/AIDS. Today we’re reading about the push for more HIV/AIDS funding, the increasing new cases of HIV, and the increase in number of individuals receiving HIV treatment. And of course, we also threw in a couple articles about NTDs as well! Enjoy.

Leaders Weigh In On Global HIV/AIDS Funding, Medical News Today
Number of HIV-positive in treatment rose by a quarter last year, Chicago Tribune
More than five million people receiving HIV treatment, Webwire
Lymphatic filariasis: education leads to big increases in numbers who comply with treatment, Paul Chinnock
Uganda: Riverblindness Falls to 7 Percent, Eriosi Nantaba, All Africa

A Closer Look at Mass Drug Administration

July 15th, 2010

By: Alanna Shaikh

Photo Courtesy of http://www.doh.gov.ph

One of the most effective ways of fighting Neglected Tropical Diseases is through Mass Drug Administration (MDA). Basically, you treat an entire population with the drug for a specific disease. The idea is that by treating everybody at once, you interrupt transmission of the disease. So you get the benefit of treatment for all the individuals involved, and you also put a major dent into the spread of the disease. (If you want to learn more about MDA, there is a good article by Peter Hotez.)

The tricky thing about doing mass administration is that it’s an awful lot of people you need consent from. As soon as people start refusing the treatment – not taking the drugs, avoiding the treatment site, keeping their kids home from school, whatever – then your drug administration isn’t so mass any more. The people who get treated still benefit but you lose the multiplier effect of getting the whole population at once. In a worst case scenario, people do partial treatments. Then there is no individual benefit, no mass treatment benefit, and you run the risk of causing resistance to the drug treatment.

» Read more: A Closer Look at Mass Drug Administration